Matrix Private Capital Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-2,668
Closed -$241K 224
2022
Q2
$241K Sell
2,668
-78
-3% -$7.9K 0.14% 135
2022
Q1
$306K Buy
2,746
+39
+1% +$4.12K 0.15% 124
2021
Q4
$282K Sell
2,707
-737
-21% -$85.3K 0.13% 141
2021
Q3
$434K Buy
3,444
+98
+3% +$12.7K 0.23% 91
2021
Q2
$417K Sell
3,346
-13
-0.4% -$1.63K 0.23% 96
2021
Q1
$399K Sell
3,359
-123
-4% -$14.4K 0.24% 95
2020
Q4
$410K Sell
3,482
-121
-3% -$13.3K 0.29% 85
2020
Q3
$377K Sell
3,603
-40
-1% -$4.02K 0.38% 75
2020
Q2
$336K Buy
3,643
+22
+0.6% +$2.11K 0.37% 80
2020
Q1
$328K Sell
3,621
-133
-4% -$14.1K 0.47% 66
2019
Q4
$428K Buy
+3,754
New +$412K 0.45% 68

Other funds holding MDT

Matrix Private Capital Group's MDT Position: Q3 2022 in Review

Matrix Private Capital Group sold out of Medtronic (MDT) in Q3 2022, closing a stake of 2,668 shares — an estimated $241K sold.

Matrix Private Capital Group first reported a position in MDT in Q4 2019 and held it in 11 quarters. The position peaked at $434K in Q3 2021. 1,932 funds tracked by Wall St. Rank hold MDT as of Q3 2022.

  • Matrix Private Capital Group reported no remaining Medtronic position as of Q3 2022 after selling out during the quarter.
  • Matrix Private Capital Group sold 2,668 Medtronic shares in Q3 2022, an estimated $241K.
  • Matrix Private Capital Group first reported a position in Medtronic in Q4 2019 and held it in 11 quarters.
  • Matrix Private Capital Group's Medtronic position peaked at $434K in Q3 2021.
  • 1,932 funds tracked by Wall St. Rank held Medtronic as of Q3 2022.

Based on Matrix Private Capital Group's 13F filing for Q3 2022, filed 14 Nov 2022.